Denmark's Zealand Pharma said on Thursday its experimental weight-loss drug showed an improvement in patients with a type of fatty liver disease after results from a mid-stage study were leaked, sending its shares up nearly 7%.
Zealand Pharma A/S (OTCPK:ZLDPF) Q1 2024 Results Conference Call May 16, 2024 8:00 AM ET Company Participants Anna Krassowska - VP, IR Adam Steensberg - President, CEO David Kendall - CMO Henriette Wennicke - CFO Conference Call Participants Rajan Sharma - Goldman Sachs Lucy Codrington - Jefferies Thomas Bowers - Danske Bank Laura Hindley - Berenberg Suzanne van Voorthuizen - VLK Operator Good day, and thank you for standing by. Welcome to the Q1 Financial Results Interim Report First Quarter 2024 Conference Call.